The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Open accessAbstract
PURPOSE: Previous studies suggested that serum levels of microRNA (miR)-371a-3p (so-called M371 test) have a much higher sensitivity and specificity than the classic markers of testicular germ cell tumors (GCTs) and are applicable toward both seminoma and nonseminoma. We sought to confirm the usefulness of this test as a novel biomarker for GCT. PATIENTS AND METHODS: In a prospective, multicentric study, serum samples of 616 patients with testicular GCTs and 258 male controls were examined for serum levels of miRNA-371a-3p (miR levels) by quantitative polymerase chain reaction. The GCT population encompassed 359 patients with seminoma and 257 with nonseminoma; 371 had clinical stage I disease, 201 had systemic disease, and 46 had relapses. Paired measurements before and after orchiectomy were performed in 424 patients; 118 with systemic disease had serial measurements during treatment. miR levels were compared with those of β-human chorionic gonadotropin, α-fetoprotein, and lactate dehydrogenase. RESULTS: For the primary diagnosis of GCT, the M371 test showed a sensitivity of 90.1%, a specificity of 94.0%, an area under the curve of 0.966 upon receiver operating characteristic analysis, and a positive predictive value of 97.2%. α-Fetoprotein, β-human chorionic gonadotropin, and lactate dehydrogenase had sensitivities of less than 50% in seminoma and slightly higher sensitivities in nonseminomas. miR levels were significantly associated with clinical stage, primary tumor size, and response to treatment. Relapses had elevated miR levels that subsequently dropped to normal upon remission. Teratoma did not express miR-371a-3p. CONCLUSION: The M371 test outperforms the classic markers of GCT with both a sensitivity and a specificity greater than 90%. All histologic subgroups, except teratoma, express this marker. The test could be considered for clinical implementation after further validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Guidelines on Testicular Cancer: 2015 Update
Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Fizazi, K., Horwich, A., Laguna, M. P., Nicolai, N., & Oldenburg, J. (2015) · European Urology · doi:10.1016/j.eururo.2015.07.044 · Cited by 670
Self-citationIntegrated Molecular Characterization of Testicular Germ Cell Tumors
Shen, H., Shih, J., Hollern, D. P., Wang, L., Bowlby, R., Tickoo, S. K., Thorsson, V., Mungall, A. J., Newton, Y., Hegde, A. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.039 · Cited by 454
Gilligan, T. D., Seidenfeld, J., Basch, E. M., Einhorn, L. H., Fancher, T., Smith, D. C., Stephenson, A. J., Vaughn, D. J., Cosby, R., & Hayes, D. F. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4481 · Cited by 297
Murray, M. J., Halsall, D. J., Hook, C. E., Williams, D. M., Nicholson, J. C., & Coleman, N. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpoe11keyzcjht · Cited by 227
Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
Dieckmann, K.-P., Radtke, A., Spiekermann, M., Balks, T., Matthies, C., Becker, P., Ruf, C., Oing, C., Oechsle, K., Bokemeyer, C., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.07.029 · Cited by 209
Self-citationSyring, I., Bartels, J., Holdenrieder, S., Kristiansen, G., Müller, S. C., & Ellinger, J. (2015) · Journal of Urology · doi:10.1016/j.juro.2014.07.010 · Cited by 200
The present and future of serum diagnostic tests for testicular germ cell tumours
Murray, M. J., Huddart, R. A., & Coleman, N. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.170 · Cited by 189
Gillis, A. J. M., Rijlaarsdam, M. A., Eini, R., Dorssers, L. C. J., Biermann, K., Murray, M. J., Nicholson, J. C., Coleman, N., Dieckmann, K.-P., Belge, G., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.08.002 · Cited by 159
Self-citationMurray, M. J., Bell, E., Raby, K. L., Rijlaarsdam, M. A., Gillis, A., Looijenga, L. H. J., Brown, H. J., Destenaves, B., Nicholson, J. C., & Coleman, N. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.429 · Cited by 148
Cited by
Non-coding RNAs in disease: from mechanisms to therapeutics
Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00662-1 · Cited by 885
Human germ cell tumours from a developmental perspective
Oosterhuis, J. W., & Looijenga, L. H. J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0178-9 · Cited by 328
miR-21: a non‐specific biomarker of all maladies
Jenike, A. E., & Halushka, M. K. (2021) · Biomarker Research · doi:10.1186/s40364-021-00272-1 · Cited by 248
A comprehensive overview of liquid biopsy applications in pediatric solid tumors
Janssen, F. W., Lak, N. S. M., Janda, C. Y., Kester, L. A., Meister, M. T., Merks, J. H. M., van den Heuvel-Eibrink, M. M., van Noesel, M. M., Zsiros, J., Tytgat, G. A. M., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00657-z · Cited by 32
Metadata
- Authors
- Dieckmann, K.-P., Radtke, A., Geczi, L., Matthies, C., Anheuser, P., Eckardt, U., Sommer, J., Zengerling, F., Trenti, E., Pichler, R., Belz, H., Zastrow, S., Winter, A., Melchior, S., Hammel, J., Kranz, J., Bolten, M., Krege, S., Haben, B., Loidl, W., Ruf, C. G., Heinzelbecker, J., Heidenreich, A., Cremers, J. F., Oing, C., Hermanns, T., Fankhauser, C. D., Gillessen, S., Reichegger, H., Cathomas, R., Pichler, M., Hentrich, M., Eredics, K., Lorch, A., Wülfing, C., Peine, S., Wosniok, W., Bokemeyer, C., & Belge, G.
- Venue
- Journal of Clinical Oncology
- Published
- 2019-06-01
- Volume
- 37
- Issue
- 16
- Pages
- 1412-1423
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2922255797
- Cited by
- 354
- References
- 20
- FWCI
- 40.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. https://app.cochat.ai/papers/10.1200/jco.18.01480
- The paper
- Dieckmann, K.-P., Radtke, A., Geczi, L., Matthies, C., Anheuser, P., Eckardt, U., Sommer, J., Zengerling, F., Trenti, E., Pichler, R., Belz, H., Zastrow, S., Winter, A., Melchior, S., Hammel, J., Kranz, J., Bolten, M., Krege, S., Haben, B., . . . Belge, G. (2019). Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.18.01480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.